Dow Up 0.08% Nasdaq Down 0.30%

Curis, Inc. (CRIS)

-NasdaqGM
1.52 Down 0.04(2.56%) Sep 19, 4:15PM EDT
|After Hours : 1.52 0.00 (0.00%) Sep 19, 4:40PM EDT
Prev Close:1.56
Open:1.56
Bid:1.49 x 700
Ask:1.65 x 700
1y Target Est:5.17
Beta:0.93
Earnings Date:Nov 4 - Nov 10 (Est.)
Day's Range:1.48 - 1.57
52wk Range:1.48 - 4.74
Volume:870,209
Avg Vol (3m):1,042,500
Market Cap:130.73M
P/E (ttm):N/A
EPS (ttm):-0.15
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CRISDown 2.56%130.73M
EXELDown 1.16%331.69M
INFIDown 2.24%677.77M
PFEDown 0.59%192.76B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):9.06
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.18
Quarterly EPS Est (Sep-14) :-0.04
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Curis, Inc. is engaged in the research, development, and commercialization of cancer therapeutics. It focuses on developing cancer drug candidates, including CUDC-907, an oral, small molecule drug candidate that is designed to inhibit histone deac... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback